0T6G Q32 Bio Inc.

LSE · GB · Healthcare · Biotechnology · q32bio.com

8.310USD+4.00%Mkt Cap: —P/E: —2d ago

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immu…

Key Statistics

Company

Market Cap—

Enterprise Value146.41M USD

Revenue (TTM)53.74M USD

Gross Profit39.39M USD

Net Income (TTM)33.79M USD

Revenue/Share3.62 USD

Last Price8.310 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees22

CountryGB

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA6.71

EV/Revenue2.72

P/S—

P/B1.80

EPS (TTM)-0.05

EPS (Forward)—

52W Range

7.7604% of range20.34

52W High20.34 USD

52W Low7.760 USD

Profitability

Gross Margin73.30%

Oper. Margin39.94%

EBITDA Margin40.60%

Profit Margin62.87%

ROE72.14%

ROA14.74%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-19.83M USD

CapEx (TTM)—

FCF Margin36.09%

FCF Yield—

Net Debt-100.97M USD

Net Debt/EBITDA-4.63

Balance Sheet

Debt/Equity5.00

Current Ratio20.30

Quick Ratio19.78

Book Value/Sh4.46 USD

Cash/Share3.57 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split0.055556:1

Split DateMar 26, 2024

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.37.31M

Float14.64M

Insiders2.10%

Institutions80.73%

Technical

SMA 500.6630 (+1153.3%)

SMA 2000.8770 (+847.5%)

Beta-0.11

S&P 52W Chg15.78%

Avg Vol (30d)3.56K

Avg Vol (10d)3.86K

Technical Indicators

RSI (14)28.9

MACD-1.4383

MACD Signal-1.3900

MACD Hist.-0.0483

BB Upper12.11 USD

BB Middle9.799 USD

BB Lower7.484 USD

BB Width47.25%

ATR (14)0.8643 USD

Vol Ratio (20d)0.24x

0T6G Q32 Bio Inc.

Industry Peers

Key Statistics